Product Images Kevzara

This is a graph showing the percentage of patients with ACR20 response over the course of a 24-week study. The study involved three groups: a placebo group with methotrexate (MTX), a group taking Kevzara 150 mg with MTX, and a group taking Kevzara 200 mg with MTX. The ACR20 response is measured numerically on the y-axis, and the weeks of the study are plotted on the x-axis.*

This text contains information about a medication called "KEVZARA®" (sarilumah), which is an injection with a dosage of 150 mg/114 my. The label also mentions a yellow needle cover and an orange cap. There is no other useful information provided in this text.*

This is a description of a prescription drug named KEVZARA®. It is administered via subcutaneous injection using a single-dose prefilled pen that contains 150 mg/1:14 my of the drug. The National Drug Code (NDC) for this medication is 0024.5920.0.*

This is a pre-filled pen containing 200mg of medicine and has a stated dosage of 114. It is meant for single use only and is administered via subcutaneous injection.*

KEVZARA- is a medication that comes as 150 mg/1.14 mL (131.6 mg/mL) injection in 2 single-dose pre-filled syringes designed for subcutaneous use only. The package contains a package insert, medication guide, and instructions for use. Sarilumab is the active ingredient, and each pre-filled syringe holds 114 mL of solution containing 150 mg of it. Other ingredients include arginine, histidine, polysorbate 20, glucose, and sterile water or injection without preservatives. There is no US standard of potency. KEVZARA should be stored in the original carton in a refrigerator at 36°F to 46°F (2°C to 8°C) and should be protected from light. If needed, it can be stored at room temperature up to 77°F (25°C) up to 14 days in the outer carton, but no longer. The enclosed medication guide is required for each patient. More information about dosage and administration can be found in the package insert.*

This is a description of a medicine packaging containing two single-dose pre-filled syringes, each containing 1.14mL of solution that delivers 200mg of Sarilumab. It includes a medication guide, instructions for use, and dosage information. The solution is sterile and has no preservatives, and it should be stored in a refrigerator at 36°F to 46°F in its original carton to protect it from light. The package insert should be followed, and any unused portion should be discarded in accordance with local requirements. The medicine is for subcutaneous injection use only.*

KEVZARA (sarilumab) is a medication provided in single-dose pre-filled pens for subcutaneous injection and is used to treat certain autoimmune diseases. Each pen contains 150mg of sarilumab, a solution of arginine, histidine, polysorbate, sucrose and water for injection. Each pen delivers a 50mg dose of the solution. The medication must be refrigerated at 36-46°F and protected from light. The discarded medication must be handled according to guidelines. The package contains dosing information and instructions for use. A medication guide is enclosed for each patient.*

This is a medication called KEVZARA (sarilumab) which is available in a pre-filled injection pen. It is used for subcutaneous injection and should be stored in a refrigerator at 36°F to 46°F. Dosage information and instructions for use can be found on the package insert. The medication is manufactured by Regeneron, Sanofi Genzyme.*